AERIE PHARMACEUTICALS, INC. Trademark

Trademark Overview


On Monday, February 20, 2017, a trademark application was filed for AERIE PHARMACEUTICALS, INC. with the United States Patent and Trademark Office. The USPTO has given the AERIE PHARMACEUTICALS, INC. trademark a serial number of 87342226. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 19, 2024. This trademark is owned by Aerie Pharmaceuticals, Inc.. The AERIE PHARMACEUTICALS, INC. trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development services for others in the fields of ophthalmology, medicinal chemistry, cell biology, and pharmacology; conducting research and clinical trials for others relating to pharmaceuticals in the fields of ophthalmology, medicinal chemistry, cell biology, and pharmacology
aerie pharmaceuticals, inc.

General Information


Serial Number87342226
Word MarkAERIE PHARMACEUTICALS, INC.
Filing DateMonday, February 20, 2017
Status710 - CANCELLED - SECTION 8
Status DateFriday, April 19, 2024
Registration Number5300379
Registration DateTuesday, October 3, 2017
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 18, 2017

Trademark Statements


Description of MarkThe mark consists of the word "aerie" in a stylized font under a stylized design consisting of an oval with a crescent moon to the right and the words "pharmaceuticals, inc." beneath "aerie".
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"PHARMACEUTICALS INC."
Goods and ServicesResearch and development services for others in the fields of ophthalmology, medicinal chemistry, cell biology, and pharmacology; conducting research and clinical trials for others relating to pharmaceuticals in the fields of ophthalmology, medicinal chemistry, cell biology, and pharmacology

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 19, 2024
Primary Code042
First Use Anywhere DateThursday, October 6, 2016
First Use In Commerce DateThursday, October 6, 2016

Trademark Owner History


Party NameALCON INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressFRIBOURG CH-1701
CH

Party NameAerie Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBedminster, NJ 07921

Party NameAerie Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBedminster, NJ 07921

Party NameAerie Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBedminster, NJ 07921

Trademark Events


Event DateEvent Description
Thursday, February 23, 2017NEW APPLICATION ENTERED
Thursday, May 11, 2017ASSIGNED TO EXAMINER
Wednesday, May 17, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 27, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 28, 2017NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, May 16, 2017EXAMINERS AMENDMENT E-MAILED
Tuesday, May 16, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, May 16, 2017EXAMINERS AMENDMENT -WRITTEN
Tuesday, May 16, 2017EXAMINER'S AMENDMENT ENTERED
Wednesday, June 28, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 18, 2017PUBLISHED FOR OPPOSITION
Tuesday, July 18, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 3, 2017REGISTERED-PRINCIPAL REGISTER
Friday, April 19, 2024CANCELLED SEC. 8 (6-YR)
Wednesday, March 22, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, January 29, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 3, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED